LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY
Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · 11.03.2025 · 88 (2) · 155-163
DOI: 10.26650/iuitfd.1626109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, online erschienen am 11.03.2025. Verfasst von Ecesu Çetin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Çetin, E., & Burak, M. (2025). LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 88(2), 155-163. https://doi.org/10.26650/iuitfd.1626109
Vancouver
Çetin E, Burak M. LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 2025;88(2):155-163. doi:10.26650/iuitfd.1626109
BibTeX
@article{etin2025,
author = {Çetin, Ecesu and Burak, Mehmet},
title = {LATEST ADVANCES FOR TREATING CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY},
journal = {Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi},
year = {2025},
volume = {88},
number = {2},
pages = {155--163},
doi = {10.26650/iuitfd.1626109}
}
EUVIMED